Atp1a3 Associated Neurological Disorder Cn305087
ATP1A3-associated neurological disorder affects nerve cell function due to gene mutations impacting ion transport. It can cause alternating hemiplegia, developmental delays, and seizures. Treatment is symptomatic and supportive, focusing on managing specific symptoms.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Paroxysmal alternating hemiplegia
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Seizure episodes
(neurologic)Developmental delay
(neurologic)Dystonia
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Drug therapy and clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Flunarizine calcium channel blocker therapy
Calcium channel blocker that may reduce the frequency and severity of hemiplegic episodes in ATP1A3-associated neurological disorders. Treatment requires careful evaluation by a neurologist specializing in these rare conditions.
Physical rehabilitation for motor dysfunction
Comprehensive physical therapy program addressing motor impairment, weakness, and movement disorders associated with ATP1A3 mutations. Focuses on functional mobility, strength, and balance training.
Additional treatment options
Trigger avoidance and environmental management
Identification and avoidance of known triggers such as temperature extremes, emotional stress, and fatigue that may precipitate neurological symptoms. Environmental adaptations help reduce episode frequency.
lifestyleAntiepileptic medications for seizure control
Antiepileptic drug therapy tailored to individual seizure types and patterns when seizures are present. Requires individualized selection based on seizure semiology and tolerability.
medicationRegular neurological follow-up and symptom tracking
Ongoing monitoring by neurology specialists to assess symptom progression, treatment efficacy, and emerging complications. Regular documentation helps guide treatment adjustments.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Atp1a3 Associated Neurological Disorder Cn305087?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Atp1a3 Associated Neurological Disorder Cn305087. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy